Rapidly evolving pelvic lymphangioleiomyomatosis (LAM) mimicking bilateral hydrosalpinx: report of a rare case and literature review

References

• Johnson SR, Cordier JF, Lazor R, et al. European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J. 2010;35(1):14–26. doi:10.1183/09031936.00076209.
   PubMed Web of Science ®Google Scholar
• Henske EP, McCormack FX. Lymphangioleiomyomatosis – a wolf in sheep’s clothing. J Clin Invest. 2012;122(11):3807–3816. doi:10.1172/JCI58709.
   PubMed Web of Science ®Google Scholar
• Matsui K, Tatsuguchi A, Valencia J, et al. Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic features in 22 cases. Hum Pathol. 2000;31(10):1242–1248. doi:10.1053/hupa.2000.18500.
   PubMed Web of Science ®Google Scholar
• Khaddour K, Shayuk M. Lymphangioleiomyomatosis. Treasure Island (FL): StatPearls Publishing; 2020.
   Google Scholar
• Utpatel K, Calvisi DF, Köhler G, et al. Complexity of PEComas: diagnostic approach, molecular background, clinical management. Pathologe. 2020;41(S1):9–19. doi:10.1007/s00292-019-0612-5.
   PubMedGoogle Scholar
• Krymskaya VP, McCormack FX. Lymphangioleiomyomatosis: a monogenic model of malignancy. Annu Rev Med. 2017;68(1):69–83. doi:10.1146/annurev-med-050715-104245.
   PubMedGoogle Scholar
• Shein T, Field A. Retroperitoneal lymphangioleiomyomatosis. Pathology. 2017;49:S130–S131. doi:10.1016/j.pathol.2016.09.025.
   Google Scholar
• Wahid S, Chiang PC, Luo HL, et al. Pelvic lymphangioleiomyomatosis treated successfully with everolimus: two case reports with literature review. Medicine. 2017;96(10):e4562. doi:10.1097/MD.0000000000004562.
   PubMed Web of Science ®Google Scholar
• Harknett EC, Chang WY, Byrnes S, et al. Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis. QJM. 2011;104(11):971–979. doi:10.1093/qjmed/hcr116.
   PubMed Web of Science ®Google Scholar
• Wakimoto T, Tsutsui T, Kawano M, et al. Chronic pelvic pain due to pelvic lymphangioleiomyomatosis: a case report. Gynecol Minim Invas Ther. 2016;5(2):84–87. doi:10.1016/j.gmit.2016.02.003.
   Google Scholar
• Green AJ, Smith M, Yates JRW. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nat Genet. 1994;6(2):193–196. doi:10.1038/ng0294-193.
   PubMed Web of Science ®Google Scholar
• Young L, Lee HS, Inoue Y, et al. Serum VEGF-D concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial. Lancet Respir Med. 2013;1(6):445–452. doi:10.1016/S2213-2600(13)70090-0.
   PubMed Web of Science ®Google Scholar
• McCormack FX. Lymphangioleiomyomatosis: a clinical update. Chest. 2008;133(2):507–516. doi:10.1378/chest.07-0898.
   PubMed Web of Science ®Google Scholar
• Logginidou H, Ao X, Russo I, et al. Frequent estrogen and progesterone receptor immunoreactivity in renal angiomyolipomas from women with pulmonary lymphangioleiomyomatosis. Chest. 2000;117(1):25–30. doi:10.1378/chest.117.1.25.
   PubMed Web of Science ®Google Scholar
• Ryu JH, Moss J, Beck GJ, et al. The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. Am J Respir Crit Care Med. 2006;173(1):105–111. doi:10.1164/rccm.200409-1298OC.
   PubMed Web of Science ®Google Scholar
• Prizant H, Hammes SR. Minireview: lymphangioleiomyomatosis (LAM): the "other" steroid-sensitive cancer. Endocrinology. 2016;157(9):3374–3383. doi:10.1210/en.2016-1395.
   PubMed Web of Science ®Google Scholar
• Taveira-DaSilva AM, Stylianou MP, Hedin CJ, et al. Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone. Chest. 2004;126(6):1867–1874. doi:10.1378/chest.126.6.1867.
   PubMed Web of Science ®Google Scholar
• Yu J, Henske EP. mTOR activation, lymphangiogenesis, and estrogen-mediated cell survival: the "perfect storm" of pro-metastatic factors in LAM pathogenesis. Lymphat Res Biol. 2010;8(1):43–49. doi:10.1089/lrb.2009.0020.
   PubMed Web of Science ®Google Scholar
• Lee N, Woodrum CL, Nobil AM, et al. Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models. BMC Pharmacol. 2009;9:8. doi:10.1186/1471-2210-9-8.
   PubMedGoogle Scholar
• Laganà AS, Vergara D, Favilli A, et al. Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease. Arch Gynecol Obstet. 2017;296(5):855–867. doi:10.1007/s00404-017-4515-5.
   PubMed Web of Science ®Google Scholar
• Vimercati A, Santarsiero CM, Esposito A, et al. An extremely rare case of disseminated peritoneal leiomyomatosis with a pelvic leiomyosarcoma and omental metastasis after laparoscopic morcellation: systematic review of the literature. Diagnostics. 2022;12(12):3219. doi:10.3390/diagnostics12123219.
   Web of Science ®Google Scholar
• Vander Borght M, Wyns C. Fertility and infertility: definition and epidemiology. Clin Biochem. 2018;62:2–10. doi:10.1016/j.clinbiochem.2018.03.012.
   PubMed Web of Science ®Google Scholar
• Cicinelli E, Resta L, Loizzi V, et al. Antibiotic therapy versus no treatment for chronic endometritis: a case-control study. Fertil Steril. 2021;115(6):1541–1548. doi:10.1016/j.fertnstert.2021.01.018.
   PubMed Web of Science ®Google Scholar
• Shroff S. Infectious vaginitis, cervicitis, and pelvic inflammatory disease. Med Clin North Am. 2023;107(2):299–315. doi:10.1016/j.mcna.2022.10.009.
   PubMed Web of Science ®Google Scholar
• Noventa M, Gizzo S, Saccardi C, et al. Salpingectomy before assisted reproductive technologies: a systematic literature review. J Ovarian Res. 2016;9(1):74. doi:10.1186/s13048-016-0284-1.
   PubMedGoogle Scholar
• Piccioni MG, Tabacco S, Merlino L, et al. Does hysterosalpingo-foam sonography have any therapeutic effect? A systematic review. Minerva Ginecol. 2020;72(1):55–58. doi:10.23736/S0026-4784.20.04514-1.
   PubMed Web of Science ®Google Scholar
• Riva A, Vitagliano A, Noventa M, et al. Evaluating the effectiveness of pharmacological strategies and further measures for pain relief during hysterosonosalpingography: a systematic review. Diagnostics. 2022;12(12):3185. doi:10.3390/diagnostics12123185.
   Web of Science ®Google Scholar
• Arya S, Plavsic SK. Preimplantation 3D ultrasound: current uses and challenges. J Perinat Med. 2017;45(6):745–758.
   PubMed Web of Science ®Google Scholar
• Spagnol G, Noventa M, Bonaldo G, et al. Three-dimensional transvaginal ultrasound vs magnetic resonance imaging for preoperative staging of deep myometrial and cervical invasion in patients with endometrial cancer: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2022;60(5):604–611. doi:10.1002/uog.24967.
   PubMed Web of Science ®Google Scholar